<?xml version="1.0" encoding="UTF-8"?>
<p>Animals were treated according to the protocols established by the ethics committee of Shengjing Hospital of China Medical University and the 
 <italic>in vivo</italic> experiments were carried out in accordance with the approved guidelines and approved by the ethics committee of Shengjing Hospital of China Medical University. BALB/c nude mice were purchased from Hunan Slack Scene of Laboratory Animal Co., Ltd. (Hunan, China). Xenograft models using human leukaemia cells, MOLT-4, were established in BALB/c mice. Then, mice were separated into vehicle group and treatment groups (60 mg/kg and 100 mg/kg). The treatment groups received compound 
 <bold>D6</bold> by intragastric administration for a period of 21 days.
</p>
